Tumor associated macrophages (TAMs) can suppress the effect of CD8+ T lymphocytes and promote tumor angiogenesis and metastasis (Qian and Pollard, 2010; Noy and Pollard, 2014), causing major challenges for efficient cancer immunotherapies (Mahmoud et al., 2012). Here, CD8A is linked to neoplasm.